Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
Anaemia of chronic disease (ACD) is a common feature of active rheumatoid arthritis (RA). Inflammatory cytokines, particularly tumour necrosis factor alpha (TNF-alpha), interleukin-1 (IL-1) and interleukin-6 (IL-6), are thought to contribute to the pathogenesis of ACD, possibly by inhibiting erythro...
Main Authors: | Davis, D, Charles, P, Potter, A, Feldmann, M, Maini, R, Elliott, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1997
|
Similar Items
-
Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
by: Maini, R, et al.
Published: (1995) -
Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
by: Brennan, F, et al.
Published: (1995) -
Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1997) -
TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
by: Elliott, M, et al.
Published: (1995) -
Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
by: Elliott, M, et al.
Published: (1994)